scispace - formally typeset
F

Frank D. Kolodgie

Researcher at Armed Forces Institute of Pathology

Publications -  347
Citations -  44794

Frank D. Kolodgie is an academic researcher from Armed Forces Institute of Pathology. The author has contributed to research in topics: Stent & Restenosis. The author has an hindex of 86, co-authored 338 publications receiving 41269 citations. Previous affiliations of Frank D. Kolodgie include Leidos & United States Department of Veterans Affairs.

Papers
More filters
Journal ArticleDOI

Lessons From Sudden Coronary Death A Comprehensive Morphological Classification Scheme for Atherosclerotic Lesions

TL;DR: This review will reconsider the current paradigm for understanding the critical, final steps in the progression of atherosclerotic lesions, and devise a simpler classification scheme that is consistent with the AHA categories but is easier to use, able to deal with a wide array of morphological variations, and not overly burdened by mechanistic implications.
Journal ArticleDOI

Pathology of Drug-Eluting Stents in Humans: Delayed Healing and Late Thrombotic Risk

TL;DR: The Cypher and Taxus DES result in delayed arterial healing when compared with BMS of similar implant duration, and the cause of DES LST is multifactorial with delayed healing in combination with other clinical and procedural risk factors playing a role.
Journal ArticleDOI

Pathology of the Vulnerable Plaque

TL;DR: Of the three types of coronary thrombosis, a precursor lesion for acute rupture has been postulated and the non-thrombosed lesion that most resembles the acute plaque rupture is the thin cap fibroatheroma (TCFA).
Journal ArticleDOI

Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting Stent: Should We Be Cautious?

TL;DR: The known pharmacokinetic elution profile of Cypher stents and the presence of polymer fragments surrounded by giant cells and eosinophils suggest that a reaction to the polymer may have caused late stent thrombosis.
Journal ArticleDOI

Apoptosis in Myocytes in End-Stage Heart Failure

TL;DR: Loss of myocytes due to apoptosis occurs in patients with end-stage cardiomyopathy and may contribute to progressive myocardial dysfunction.